Growth Metrics

CorMedix (CRMD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.

  • CorMedix's Income from Continuing Operations rose 400227.68% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6252.03% up from last year.
  • According to the latest figures from Q3 2025, CorMedix's Income from Continuing Operations is $108.6 million, which was up 400227.68% from $19.8 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Income from Continuing Operations ranged from a high of $108.6 million in Q3 2025 and a low of -$14.5 million during Q1 2024
  • Over the past 5 years, CorMedix's median Income from Continuing Operations value was -$7.4 million (recorded in 2021), while the average stood at $2.3 million.
  • In the last 5 years, CorMedix's Income from Continuing Operations plummeted by 6414.73% in 2022 and then soared by 400227.68% in 2025.
  • CorMedix's Income from Continuing Operations (Quarter) stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then dropped by 18.7% to -$9.7 million in 2023, then skyrocketed by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
  • Its Income from Continuing Operations was $108.6 million in Q3 2025, compared to $19.8 million in Q2 2025 and $20.6 million in Q1 2025.